Literature DB >> 25981506

Performance of CMR Methods for Differentiating Acute From Chronic MI.

Martijn W Smulders1, Sebastiaan C A M Bekkers1, Han W Kim2, Lowie M R Van Assche3, Michele A Parker3, Raymond J Kim4.   

Abstract

OBJECTIVES: The purpose of this study was to assess the performance of cardiac magnetic resonance (CMR) methods for discriminating acute from chronic myocardial infarction (MI).
BACKGROUND: Although T2-weighted CMR is thought to be accurate in differentiating acute from chronic MI, few studies have reported on diagnostic accuracy, and these generally compared extremes in infarct age (e.g., <1 week old vs. more than 6 months old) and did not evaluate other CMR methods that could be informative.
METHODS: A total of 221 CMR studies were performed at various time points after ST-segment elevation myocardial infarction in 117 consecutive patients without a history of MI or revascularization enrolled prospectively at 2 centers. Imaging markers of acute MI (<1 month) were T2 hyperintensity on double inversion recovery turbo spin echo (DIR-TSE) images, microvascular obstruction (MO) on delayed-enhancement CMR, and focally increased end-diastolic wall thickness (EDWT) on cine-CMR.
RESULTS: The prevalence of T2-DIR-TSE hyperintensity decreased with infarct age but remained substantial up to 6 months post-MI. In contrast, the prevalence of both MO and increased EDWT dropped sharply after 1 month. T2-DIR-TSE sensitivity, specificity, and accuracy for identifying acute MI were 88%, 66%, and 77% compared with 73%, 97%, and 85%, respectively, for the combination of MO or increased EDWT. On multivariable analysis, persistence of T2-hyperintensity in intermediate-age infarcts (1 to 6 months old) was predicted by larger infarct size, diabetes, and better T2-DIR-TSE image quality score. For infarct size ≥ 10% of the left ventricle, a simple algorithm incorporating all CMR components allowed classification of infarct age into 3 categories (<1 month old, 1 to 6 months old, and ≥ 6 months old) with 80% (95% confidence interval: 73% to 87%) accuracy.
CONCLUSIONS: T2-DIR-TSE hyperintensity is specific for infarcts <6 months old, whereas MO and increased EDWT are specific for infarcts <1 month old. Incorporating multiple CMR markers of acute MI and their varied longevity leads to a more precise assessment of infarct age.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  T2-weighted CMR; acute MI; microvascular obstruction

Mesh:

Year:  2015        PMID: 25981506      PMCID: PMC4465991          DOI: 10.1016/j.jcmg.2014.12.030

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  26 in total

1.  T2-weighted cardiac MR assessment of the myocardial area-at-risk and salvage area in acute reperfused myocardial infarction: comparison of state-of-the-art dark blood and bright blood T2-weighted sequences.

Authors:  Magalie Viallon; Nathan Mewton; Franck Thuny; Jens Guehring; Thomas O'Donnell; Alto Stemmer; Xiaoming Bi; Stanislas Rapacchi; Sven Zuehlsdorff; Didier Revel; Pierre Croisille
Journal:  J Magn Reson Imaging       Date:  2011-09-29       Impact factor: 4.813

2.  Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling.

Authors:  Adam N Mather; Timothy A Fairbairn; Nigel J Artis; John P Greenwood; Sven Plein
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

3.  An improved MR imaging technique for the visualization of myocardial infarction.

Authors:  O P Simonetti; R J Kim; D S Fieno; H B Hillenbrand; E Wu; J M Bundy; J P Finn; R M Judd
Journal:  Radiology       Date:  2001-01       Impact factor: 11.105

4.  Clinical implications of microvascular obstruction and intramyocardial haemorrhage in acute myocardial infarction using cardiovascular magnetic resonance imaging.

Authors:  Sebastiaan C A M Bekkers; Martijn W Smulders; Valéria Lima Passos; Tim Leiner; Johannes Waltenberger; Anton P M Gorgels; Simon Schalla
Journal:  Eur Radiol       Date:  2010-06-26       Impact factor: 5.315

Review 5.  MRI in acute myocardial infarction.

Authors:  Martina Perazzolo Marra; João A C Lima; Sabino Iliceto
Journal:  Eur Heart J       Date:  2010-11-25       Impact factor: 29.983

6.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

Authors:  J S Alpert; K Thygesen; E Antman; J P Bassand
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

7.  Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI.

Authors:  Nilesh R Ghugre; Venkat Ramanan; Mihaela Pop; Yuesong Yang; Jennifer Barry; Beiping Qiang; Kim A Connelly; Alexander J Dick; Graham A Wright
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

8.  Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial.

Authors:  Raymond J Kim; Timothy S E Albert; James H Wible; Michael D Elliott; John C Allen; Jennifer C Lee; Michele Parker; Alicia Napoli; Robert M Judd
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

Review 9.  Assessment of acute myocardial infarction: current status and recommendations from the North American society for Cardiovascular Imaging and the European Society of Cardiac Radiology.

Authors:  Arthur E Stillman; Matthijs Oudkerk; David Bluemke; Jens Bremerich; Fabio P Esteves; Ernest V Garcia; Matthias Gutberlet; W Gregory Hundley; Michael Jerosch-Herold; Dirkjan Kuijpers; Raymond K Kwong; Eike Nagel; Stamatios Lerakis; John Oshinski; Jean-François Paul; Richard Underwood; Bernd J Wintersperger; Michael R Rees
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-24       Impact factor: 2.357

10.  Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease.

Authors:  Han W Kim; Igor Klem; Dipan J Shah; Edwin Wu; Sheridan N Meyers; Michele A Parker; Anna Lisa Crowley; Robert O Bonow; Robert M Judd; Raymond J Kim
Journal:  PLoS Med       Date:  2009-04-21       Impact factor: 11.069

View more
  8 in total

1.  Pulmonary fibrosis: tissue characterization using late-enhanced MRI compared with unenhanced anatomic high-resolution CT.

Authors:  Lisa P Lavelle; Darragh Brady; Sinead McEvoy; David Murphy; Brian Gibney; Annika Gallagher; Marcus Butler; Fionnula Shortt; Marie McMullen; Aurelie Fabre; David A Lynch; Michael P Keane; Jonathan D Dodd
Journal:  Diagn Interv Radiol       Date:  2017 Mar-Apr       Impact factor: 2.630

2.  Multiparametric CMR imaging of infarct remodeling in a percutaneous reperfused Yucatan mini-pig model.

Authors:  David Lopez; Jonathan A Pan; Peter M Pollak; Samantha Clarke; Christopher M Kramer; Mark Yeager; Michael Salerno
Journal:  NMR Biomed       Date:  2017-02-06       Impact factor: 4.044

Review 3.  Recent Advances in Fibrosis and Scar Segmentation From Cardiac MRI: A State-of-the-Art Review and Future Perspectives.

Authors:  Yinzhe Wu; Zeyu Tang; Binghuan Li; David Firmin; Guang Yang
Journal:  Front Physiol       Date:  2021-08-03       Impact factor: 4.566

4.  Cardiac inflammation and ventricular tachycardia in Chagas disease.

Authors:  Hilary Shapiro; Sheba Meymandi; Kalyanam Shivkumar; Jason S Bradfield
Journal:  HeartRhythm Case Rep       Date:  2017-06-20

Review 5.  Cardiac MRI Endpoints in Myocardial Infarction Experimental and Clinical Trials: JACC Scientific Expert Panel.

Authors:  Borja Ibanez; Anthony H Aletras; Andrew E Arai; Hakan Arheden; Jeroen Bax; Colin Berry; Chiara Bucciarelli-Ducci; Pierre Croisille; Erica Dall'Armellina; Rohan Dharmakumar; Ingo Eitel; Rodrigo Fernández-Jiménez; Matthias G Friedrich; David García-Dorado; Derek J Hausenloy; Raymond J Kim; Sebastian Kozerke; Christopher M Kramer; Michael Salerno; Javier Sánchez-González; Javier Sanz; Valentin Fuster
Journal:  J Am Coll Cardiol       Date:  2019-07-16       Impact factor: 24.094

6.  Cardiovascular magnetic resonance accurately detects obstructive coronary artery disease in suspected non-ST elevation myocardial infarction: a sub-analysis of the CARMENTA Trial.

Authors:  Yvonne J M van Cauteren; Martijn W Smulders; Ralph A L J Theunissen; Suzanne C Gerretsen; Bouke P Adriaans; Geertruida P Bijvoet; Alma M A Mingels; Sander M J van Kuijk; Simon Schalla; Harry J G M Crijns; Raymond J Kim; Joachim E Wildberger; Jordi Heijman; Sebastiaan C A M Bekkers
Journal:  J Cardiovasc Magn Reson       Date:  2021-03-22       Impact factor: 5.364

7.  Reducing redundant creatine kinase testing in cardiac injury.

Authors:  Sheharyar Raza; Andre C Amaral; Jeffrey Pang; Fuad Moussa; Dominick Shelton; Lowyl Notario; Heather Harrington; Jeannie L Callum; Paul M Yip
Journal:  BMJ Open Qual       Date:  2020-12

Review 8.  Clinical Translation of Three-Dimensional Scar, Diffusion Tensor Imaging, Four-Dimensional Flow, and Quantitative Perfusion in Cardiac MRI: A Comprehensive Review.

Authors:  Sophie Paddock; Vasiliki Tsampasian; Hosamadin Assadi; Bruno Calife Mota; Andrew J Swift; Amrit Chowdhary; Peter Swoboda; Eylem Levelt; Eva Sammut; Amardeep Dastidar; Jordi Broncano Cabrero; Javier Royuela Del Val; Paul Malcolm; Julia Sun; Alisdair Ryding; Chris Sawh; Richard Greenwood; David Hewson; Vassilios Vassiliou; Pankaj Garg
Journal:  Front Cardiovasc Med       Date:  2021-07-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.